English Germany Japanese Korean

湖北省法码斯生物科技有限公司 公司信息

公司名称: 湖北省法码斯生物科技有限公司
电话: 027-19050701
电子邮件:cbbspring@163.com
国籍:中国
网址: www.hbpharmastandard.com
产品总数:371
1 2 3 4

公司提供产品列表

β-NETA 2-(BETA-萘甲酰基)乙基三甲基碘化铵 31059-54-8
Pantothenicacid calciumsalt impurity B 泛酸钙EP-ZB
Rivaroxaban impurityA 利伐沙班杂质A 865479-71-6
Norfloxacin impurity C 诺氟沙星EP-ZC 177554-64-2
Topiroxostat impurity 20 托匹司他Z20 161233-97-2
Pantothenicacid calciumsalt impurity G 泛酸钙EP-ZG 2140-53-6
Tolterodine impurity Z17; 2-(3-amino-1-phenylpropyl)-4-methylphenol hydrochloride 托特罗定Z17
formoterol impurity I 福莫特罗EP-ZI 67346-50-3
Pantothenicacid calciumsalt impurity Z04; ethyl (R)-3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate 泛酸钙Z04
Milrinone impurity Z10 米力农Z10 2153433-47-5
Rivaroxaban impurityE 利伐沙班杂质E 1415566-28-7
Tolterodine impurity Z14 托特罗定Z14 1380491-70-2
Rivaroxaban impurityB 利伐沙班杂质B 1429334-00-8
Topiroxostat impurity 16 托匹司他Z14 4329-78-6
Norfloxacin impurity G 诺氟沙星EP-ZG 70459-04-0
Milrinone impurity Z05 米力农Z05 80047-38-7
Topiroxostat impurity 19 托匹司他Z19 2044706-68-3
Norfloxacin impurity Z13; 9-chloro-6-ethyl-8-fluoro-4-oxo-4,6-dihydro-2H-1l3,2l4-[1,3,2]dioxaborinino[5,6-c]quinoline-2,2-diyl diacetate 诺氟沙星EP-Z13
Krass intermediate 01 KRAS中间体 2936672-10-3
Milrinone impurity Z11 米力农Z11 6302-03-0
Tolterodine impurity A 托特罗定EP-ZA 124937-73-1
Sitagliptin impurity FP-D 西格列汀FP-D 1253056-18-6
Sitagliptin impurity B 西格列汀EP-ZB 486460-31-5
Tolterodine impurity Z07 托特罗定Z07 380636-49-7
Norfloxacin impurity D 诺氟沙星EP-ZD 75001-82-0
Rivaroxaban impurityJ 利伐沙班杂质J 1632463-24-1
formoterol impurity E 福莫特罗EP-ZE 1616967-26-0
Tolterodine impurity D; N-isopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropan-1-amine hydrochloride 托特罗定EP-ZD 1391053-65-8
Milrinone impurity Z06 米力农Z06 80442-07-5
Rivaroxaban impurity01; 利伐沙班杂质01
Milrinone impurity Z12 米力农Z12 6302-02-9
Topiroxostat impurity 13 托匹司他Z13 2044706-50-3
Rivaroxaban impurity02 利伐沙班杂质02 1879933-39-7
Krass 中间体1，G-82a 2936672-09-0
Sitagliptin impurity FP-E 西格列汀FP-E 936630-57-8
Rivaroxaban impurityF 利伐沙班杂质F 24065-33-6
Tolterodine impurity Z10 托特罗定Z10 848768-06-9
Topiroxostat impurity 02 托匹司他Z02 38634-05-8
Norfloxacin impurity Z04 诺氟沙星EP-Z04 75001-63-7
formoterol impurity H 福莫特罗EP-ZH 1337876-26-2
Topiroxostat impurity 01 托匹司他Z01 2044704-74-5
Tolterodine impurity C 托特罗定EP-ZC 1161940-88-0
Pantothenicacid calciumsalt impurity C 泛酸钙EP-ZC 599-04-2
Tolterodine impurity Z12 托特罗定Z12 851789-43-0
Rivaroxaban impurityD 利伐沙班杂质D 1365267-35-1
RO5166017 化合物 T34373 1048346-74-2
Topiroxostat impurity 17 托匹司他Z17 36770-53-3
Topiroxostat impurity 10 托匹司他Z10 577778-82-6
Norfloxacin impurity H 诺氟沙星EP-ZH 105440-01-5
Sitagliptin impurity FP-C 西格列汀FP-C 1803026-58-5
Topiroxostat impurity 05 托匹司他Z05 31599-25-4
Milrinone impurity Z02 米力农Z02 717818-05-8
Topiroxostat impurity 23 托匹司他Z23 21379-40-8
Pantothenicacid calciumsalt impurity H; 3-(5-(1-hydroxy-2-methylpropan-2-yl)-4-oxooxazolidin-3-yl)propanoic acid 泛酸钙EP-ZH
Topiroxostat impurity 04; 4,4'-(5,5'-(pyridine-2,4-diyl)bis(4H-1,2,4-triazole-5,3-diyl))dipyridine 托匹司他Z04
Topiroxostat impurity 21; 2-cyanoisonicotinamide 托匹司他Z21 98273-47-3
Tolterodine impurity Z08 托特罗定Z08 854306-72-2
Norfloxacin impurity J; 6,7-bis(4-(ethoxycarbonyl)piperazin-1-yl)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 诺氟沙星EP-ZJ
Rivaroxaban impurity03 利伐沙班杂质03 1365267-37-3
Topiroxostat impurity 07 托匹司他Z07 1992028-94-0
formoterol impurity F 福莫特罗EP-ZF 1795129-59-7
Sitagliptin impurity FP-A 西格列汀FP-A 2088771-60-0
Topiroxostat impurity 22 托匹司他Z22 2050015-91-1
Topiroxostat impurity 18 托匹司他Z18 135048-32-7
Tolterodine impurity E 托特罗定EP-ZE 480432-14-2
formoterol impurity B 福莫特罗EP-ZB 1224588-66-2
formoterol impurity C 福莫特罗EP-ZC 1795135-61-3
Topiroxostat impurity 24; methyl 4-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)picolinate 托匹司他Z24
Milrinone impurity Z09 米力农Z09 156033-07-7
Tolterodine impurity G 托特罗定EP-ZG 1554029-91-2
Topiroxostat impurity 03 托匹司他Z03 2044706-78-5
Norfloxacin impurity A 诺氟沙星EP-ZA 68077-26-9
Sitagliptin impurity FP-B 西格列汀FP-B 2805078-75-3
Rivaroxaban impurity05 利伐沙班杂质05
Tolterodine impurity Z25 托特罗定Z25 109089-77-2
Rivaroxaban impurityH 利伐沙班杂质H 1770812-37-7
Topiroxostat impurity 14 托匹司他Z14 6975-73-1
β-NETA intermediate 3-(二甲基氨基)-1-(2-萘)-1-丙酮 2752-87-6
Topiroxostat impurity 28; (Z)-isonicotinohydrazonamide 托匹司他Z28
Pantothenicacid calciumsalt impurity D 泛酸钙EP-ZD 50692-78-9
formoterol impurity G 福莫特罗EP-ZG 3706-26-1
Tolterodine impurity Z11 托特罗定Z11 209747-04-6
Norfloxacin impurity B 诺氟沙星EP-ZB 75001-77-3
Topiroxostat impurity 06 托匹司他Z06 2044702-36-3
Rivaroxaban impurity04 利伐沙班杂质04 1411775-06-8
Topiroxostat impurity 12; 2-cyano-4-(3-(1-oxidopyridin-4-yl)-1H-1,2,4-triazol-5-yl)pyridine 1-oxide 托匹司他Z12
Topiroxostat impurity 11 托匹司他Z11 2044708-04-3
Pantothenicacid calciumsalt impurity E 泛酸钙EP-ZE 897045-90-8
Pantothenicacid calciumsalt impurity Z05 泛酸钙Z05 505-47-5
Tolterodine impurity Z09 托特罗定Z09 40546-94-9
Rivaroxaban impurityG 利伐沙班杂质G 446292-08-6
Rivaroxaban impurityK 利伐沙班杂质K 1365267-36-2
RO5263397 化合物 T12745 1357266-05-7
Topiroxostat impurity 09 托匹司他Z09 1841081-71-7
Sitagliptin impurity A 西格列汀EP-ZA 823817-55-6
Sitagliptin impurity C 西格列汀EP-ZC 945261-48-3
formoterol impurity D 福莫特罗EP-ZD 1795133-96-8
formoterol impurity A 福莫特罗EP-ZA 150513-24-9
Milrinone impurity Z07 米力农Z07 106637-42-7
Topiroxostat impurity 25; 4-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)picolinohydrazide 托匹司他Z25
1 2 3 4
Copyright 2007© ChemicalBook. All rights reserved.